Home / About Us / Corporate Supporters Corporate Supporters Lung Cancer Canada thanks the following organizations for their support of our various 2019 activities: About Us Board of Directors Medical Advisory Committee Groups & Committees Corporate Supporters Careers LCC Newsletters Current News Urgent Changes Needed Cancer patient groups across Canada call for 2nd COVID-19 dose to be given to cancer patients according to best evidence- 21 to 28 days, not 4 weeks. Read More Alberta Changes 2nd COVID-19 Vaccine Dose Guidelines Alberta approves 21 or 28 day COVID-19 vaccine interval for cancer patients on active treatment Read More Questions To Ask Clinical Trials Patient Stories Community Activities Donate Now Peer to Peer Network
Home / About Us / Corporate Supporters Corporate Supporters Lung Cancer Canada thanks the following organizations for their support of our various 2019 activities: About Us Board of Directors Medical Advisory Committee Groups & Committees Corporate Supporters Careers LCC Newsletters Current News Urgent Changes Needed Cancer patient groups across Canada call for 2nd COVID-19 dose to be given to cancer patients according to best evidence- 21 to 28 days, not 4 weeks. Read More Alberta Changes 2nd COVID-19 Vaccine Dose Guidelines Alberta approves 21 or 28 day COVID-19 vaccine interval for cancer patients on active treatment Read More Questions To Ask Clinical Trials Patient Stories Community Activities Donate Now Peer to Peer Network
.png.aspx "Copy-of-glossary-final-(41).png")